Skip to main content
ImmuneCited

Resveratrol for Chronic Inflammation

C

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

The Bottom Line

Preclinical models demonstrate immunomodulatory and anti-inflammatory effects through SIRT1 and NF-kB modulation. Human trials show reduction in CRP and other inflammatory markers, though low oral bioavailability remains a key limitation.

Key Study Findings

Review
Modulating Ferroptosis in Aging: The Therapeutic Potential of Natural Products.
Dose: None vs: None Outcome: None Effect: None None

Population: None

In Vitro
Resveratrol derivative SH-707 inhibits NLRP3 inflammasome activation via a sirtuin 1-dependent pathway.
Dose: None vs: LPS-induced septic mouse model vs control Outcome: IL-1β secretion and NLRP3 inflammasome activation Effect: None None

Population: Macrophages and LPS-induced septic mouse model

Other
Gut microbiota-metabolite crosstalk mediates icariin's protection against obesity-induced spermatogenic dysfunction through NF-κB/AMH axis in Sertoli …
Dose: None vs: HFD mouse model vs control Outcome: Testicular morphology and spermatogenesis markers Effect: None None

Population: HFD-induced obese mouse model (spermatogenesis)

Key Statistics

5

Studies

300

Participants

Positive

C

Grade

Referenced Papers

Voprosy pitaniia 2023 19 citations
Cancer investigation 2023 6 citations
European journal of … 2020 91 citations
International journal of … 2018 248 citations
Current medicinal chemistry 2018 13 citations
Current pharmacology reports 2015
Current drug targets 2006 92 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
150-500 mg/day
immunesupport:
250-500 mg/day trans-resveratrol

Upper limit: No established UL; generally well-tolerated up to 1,500 mg/day

Dosages Studied in Research

Dosage Duration Effect N
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

Best taken: With meals

Safety & Side Effects

Reported Side Effects

  • Gastrointestinal discomfort (nausea, diarrhea)
  • Headache
  • Joint pain at very high doses (>2.5 g/day)
  • Kidney issues at extremely high doses (case reports)

Known Interactions

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • CYP1A2, CYP3A4 substrates (may inhibit metabolism)
  • Estrogen-sensitive conditions (weak estrogenic activity)

Tolerable upper intake: No established UL; generally well-tolerated up to 1,500 mg/day

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Resveratrol help with Chronic Inflammation?
Based on 5 studies with 300 participants, there is limited but promising evidence that Resveratrol may support Chronic Inflammation management. Our evidence grade is C (Some Evidence).
How much Resveratrol should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 150-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea), Headache, Joint pain at very high doses (>2.5 g/day), Kidney issues at extremely high doses (case reports). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and Chronic Inflammation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 5 peer-reviewed studies with 300 total participants. The overall direction of effect is positive.

Related Evidence

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.